{"id":28776,"date":"2023-04-15T23:52:44","date_gmt":"2023-04-15T20:52:44","guid":{"rendered":"https:\/\/www.asperbio.com\/?page_id=28776"},"modified":"2023-09-28T00:03:22","modified_gmt":"2023-09-27T21:03:22","slug":"kombineeritud-imuunpuudulikkusega-seotud-geenide-paneel","status":"publish","type":"page","link":"https:\/\/www.asperbio.com\/et\/asper-immunogenetics-testid\/kombineeritud-imuunpuudulikkusega-seotud-geenide-paneel\/","title":{"rendered":"Kombineeritud immuunpuudulikkusega seotud geenide paneel"},"content":{"rendered":"<h2 style=\"padding-left: 5px; text-align: left;\"><span style=\"color: #a2c4e8;\"><b>Kombineeritud immuunpuudulikkusega seotud geenide paneel<\/b><br \/>\n<\/span><\/h2>\n<div class=\"sm_post_content\" style=\"background: url('https:\/\/www.asperbio.com\/wp-content\/uploads\/Paternity-01.png') repeat-y; padding-left: 40px;\">\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Geen:<\/strong><\/td>\n<td><em>ADA, AK2, B2M, BCL10, CARD11, CD247, CD3D, CD3E, CD3G, CD3Z, CD40, CD40LG, CD8A, CHD7, CHUK, CIITA, COPG1, CORO1A, DCLRE1C, DOCK2, DOCK8, FCHO1, FOXN1, ICOS, ICOSLG, IKBKB, IKZF1, IKZF2, IL2RG, IL21, IL21R, IL7R, IRAK4, ITK, ITPKB, JAK3, LAT, LCK, LIG4, LPC2 (ANXA2), MALT1, MAN2B2, MAP3K14, MSN, MTHFD1, MYD88, NBN (NBS1), NHEJ1, ORAI1, PAX1, SLC46A1 (PCFT), PGM3, PNP, POLD1, POLD2, PRKDC, PTPRC, RAC2, RAG1, RAG2, REL, RELA, RELB, RFX5, RFXANK (RFX-B), RFXAP, RHOH, SASH3, STIM1, STK4, ZAP70, TAP1, TAP2, TAPBP, TBX1, TFRC, TIRAP, TLR7, TLR8, TNFRSF4, TTC7A, UNC119<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Metoodika:<\/strong><\/td>\n<td>Kodeeriva piirkonna sekveneerimine (NGS).<br \/>\nKoopiaarvu muutuste bioinformaatiline anal\u00fc\u00fcs (CNV). CNV leidude kinnitamine teise meetodiga toimub lisaanal\u00fc\u00fcsina, vastavalt hinnakirjale.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Testi valmimisaeg:<\/strong><\/td>\n<td>6-9 n\u00e4dalat<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>N\u00f5uded proovi-materjalile:<\/strong><\/td>\n<td>2-4 ml t\u00e4isverd antikoagulandiga EDTA (lilla korgiga katsuti)<\/p>\n<p>1 \u00b5g DNA-d elueerituna TE, AE puhvris v\u00f5i steriilses vees, kontsentratsiooniga 100-250 ng\/\u00b5l<br \/>\nDNA saata toatemperatuuril v\u00f5i k\u00fclmutatuna. A260\/A280 suhe peaks olema 1.8-2.0. DNA peab agaroosgeelis pikkusmarkeri juuresolekul olema detekteeritav \u00fche tervikliku b\u00e4ndina.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Tellimine:<\/strong><\/td>\n<td>Proovimaterjal saata koos <span style=\"color: #a2c4e8;\"><strong><a style=\"color: #a2c4e8;\" href=\"https:\/\/www.asperbio.com\/wp-content\/uploads\/Immunogeneetika_portfelli_saatekiri_20032023.docx\">saatekirjaga<\/a><\/strong><\/span> Asper Biogene laborisse<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<\/div>\n<p style=\"text-align: justify;\">","protected":false},"excerpt":{"rendered":"<p>Kombineeritud immuunpuudulikkusega seotud geenide paneel Geen: ADA, AK2, B2M, BCL10, CARD11, CD247, CD3D, CD3E, CD3G, CD3Z, CD40, CD40LG, CD8A, CHD7, CHUK, CIITA, COPG1, CORO1A, DCLRE1C, DOCK2, DOCK8, FCHO1, FOXN1, ICOS, ICOSLG, IKBKB, IKZF1, IKZF2, IL2RG, IL21, IL21R, IL7R, IRAK4, ITK, ITPKB, JAK3, LAT, LCK, LIG4, LPC2 (ANXA2), MALT1, MAN2B2, MAP3K14, MSN, MTHFD1, MYD88, NBN (NBS1), [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"parent":28734,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-28776","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/comments?post=28776"}],"version-history":[{"count":3,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28776\/revisions"}],"predecessor-version":[{"id":29071,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28776\/revisions\/29071"}],"up":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28734"}],"wp:attachment":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/media?parent=28776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}